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Abstract 
 
Many studies have shown that macrophages play a critical role in metastasis within the 
tumor microenvironment.  The aim of this study was to shed more light on the particular 
role of macrophages, and how the cell cycle transcription factor E2F3 affects tumor 
development and tumor metastasis.  MMTV-PyMT was used to induce tumors in the 
mammary glands of female mice.  It has been shown that Lys cre is very effective at 
specifically deleting genes in the macrophages. Lys cre was used to knock out the floxed 
E2F3 allele in the macrophages of these PyMT mice.  E2F3 PCR was used to confirm 
that the Lys cre was working at an effective level in terms of deletion efficiency.  Three 
groups of mice were generated from the breeding scheme.  There was the control group 
(E2F3+/loxp - cre), the conditional group (E2F3+/loxp + cre), and the homozygous group 
(E2F3loxp/loxp + cre).  Tumor onset in the PyMT mice population was on average 80.2 
days.  After 110 days, the mice were harvested and their tumors and lungs removed for 
analysis.  The analysis of the tumors showed that the three groups of mice had very 
similar tumor burden and dimensions.  However, the analysis of the lungs showed more 
then a three fold difference in total area of metastasis between the +/loxP -cre and +/loxP 
+cre groups. 
 
Aim of the Study: 
The aim of this study is to find out more about the role that E2F3 plays in the 
macrophage during metastasis.   
Introduction: 
 
Breast Cancer: 
 
The ACS estimates that in the year 2007 40,460 women in the United States will 
die from breast cancer.  Only Lung cancer will claim more victims this year.  This makes 
breast cancer one of the leading causes of death in women.  What makes breast cancer so 
deadly is the tendency of tumors in the mammary gland to metastasize and spread to 
other locations within the body.  Tumors tend to undergo many morphological changes 
before they metastasize. 
 
Stages of Tumor Development: 
 
 Tumor cells undergo six major changes at the cellular level that allows them to 
metastasize and spread within the body.  According to Hanahan and Weinberg (2000) 
these traits are self-sufficiency from external growth signals, non-responsiveness to 
negative growth signals, escape from apoptosis, unrestricted replication, stable 
angiogenesis, and the ability to migrate and invade other tissue.  Tumors also undergo 
changes at the pathological level.  With the model used for this experiment, there are 
certain tumor stages that can be clearly identified as the lesion progresses.  The starting 
place is called the primary tumor, and is the site where the tumor first arose.   The 
hyperplasic stage is characterized by clusters of densely grouped cells that aggregate 
around the milk-collecting duct (Lin et al., 2003).  This is followed by Adenoma and 
early/late carcinoma stages.  As the tumor progresses through these stages, the cell 
morphology becomes noticeably altered, and the cells increase in malignant potential 
until they metastasize. 
 
Tumor Microenvironment: 
 
 The tumor microenvironment is composed of many types of cells, not just 
cancerous ones.  This complex and diverse organization of cells is comprised of 
endothelial cells, fibroblasts, granulocytes, mast cells, T, B and NK cells, as well as 
dendritic cells, and macrophages (Albini & Sporn, 2007).  All these cellular components 
within the microenvironment in some way affect the development and invasive properties 
of the tumor.  As a result, recent studies have shown that the surrounding cells can 
modify primary oncogenic events in tumor cells (Pollard, 2004).  Researchers have 
identified the products of genes such as epiregulin, and cyclooxygenase-2 that might me 
involved directly in metastasis in other cancer models (Christofori, 2007).   
 
Macrophages: 
 
Most of the research that has been done on breast cancer has focused primarily on 
the malignant epithelial cells.  However, recently focus has shifted to other cell types and 
specially the macrophage.  Macrophages originate from precursor cells called monocytes.  
Their primary role is in both innate and cell-mediated immunity.  
 
 
 
 
A macrophage 
 
 They phagocytize bacteria and other pathogens, and also serve as antigen 
presenting cells (APC).  As an APC they are capable of signaling to other cells of the 
immune system such as lymphocytes, by secreting cytokines.  However, within the tumor 
microenvironment the role of a macrophage expands and they are now called TAMs or 
tumor associated macrophages.  Within the tumor, TAMs are able to secrete angiogenic 
factors, remodel and repair tissue, as well as release growth and migrations factors 
(Condeelis & Pollard, 2006).  As a result of this, macrophages are thought to play a 
critical role in tumor intravasion.  
 
E2F Family: 
 
 The genes that allow macrophages to infiltrate and aid in the intravasion of 
malignant epithelial cells are still unknown.  However, research is currently being done 
on the E2F family of genes.  The E2F gene family can be separated into three groups 
based on their different functions.  E2F 1-3 are transcriptional activators of downstream 
genes such as c-myc involved in the progression of the cell towards S-phase.  E2F 4 and 5 
have a transcription repressing role (Trimarchi & Lees, 2004).  
 
 E2F6 also represses certain genes through a different transcriptional pathway (Trimarchi 
& Lees, 2004).  E2F7 and 8 are recently discovered and their function is still under 
investigation.  Evidence has shown that the E2F1–3 subgroup are transcription factors 
that are required for cells to enter the S-phase of the cell cycle (Wu et al., 2001).  The 
tumor suppressor pRB inhibits the activity of the E2F genes. Only through cell-cycle 
dependent hyper-phosphorylation by CDK4/6 and cyclin D does it release the active E2F.  
This mechanism is being carefully studied as defects in pRB and over expression of the 
genes that the E2Fs activate are common mutations in many human cancers.  This paper 
focuses primarily on the E2F3 gene, which shows two transcriptional variations in E2F3a 
and E2F3b.  They are both similar however; E2F3b lacks the amino terminal domain 
(Trimarchi & Lees, 2004). The E2F3 gene is believed to have a critical role in the 
proliferation and differentiation of the macrophage.  
 
E2F Family of Transcription Factors 
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The domains of the E2F genes and their respective subgroups. 
 
Recent evidence suggests that CSF-1 and E2F3 may share a common pathway.  CSF-1 is 
a protein that binds to the receptor CSF-1R.  This receptor is primarily expressed in the 
monocyte lineage, the precursors to macrophages. CSF-1 is necessary during the G1 
phase of the cell cycle because it regulates several important early and late response 
genes. Cells expressing the CSF-1R receptor on stimulation with CSF-1 lead to induction 
in the expression of E2F1-3. 
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Objectives: 
 
 The mice were allowed to develop tumors for 110 days and then their tumors and 
lungs were harvested and analyzed.  The aim of this study is to find out more about tumor 
development and the role that E2F3 plays in the macrophage during metastasis.  Analysis 
for tumors in the lungs allowed for a good measure as to the amount of metastasis that 
had occurred in each individual mouse.  It is known that macrophages play a crucial role 
in metastasis perhaps by secreting certain proteases which allow malignant epithelial 
cells to escape or by other means. 
Materials and Methods 
 
Breeding: 
 
 Mice were used in this study which carried the polyoma virus middle T 
oncoprotein (PyMT).  Expression of PyMT is controlled by the mammary tumor virus 
LTR (MMTV LTR) promoter.  This promoter only allows PyMT to be active in the 
epithelial cells of the mammary gland.  This model is used to induce tumors, and studies 
have shown that PyMT is a strong oncogene that has been linked to increase c-myc levels 
among other pathways (Lin et al., 2003).  Other studies also suggest that PyMT 
associates with the Src family of tyrosine kinase signaling proteins (Webster et al., 1998)   
   Traditional E2F3 knockout mice are embryonically lethal and only survive to 
11.5 days.  To get around this problem, the Cre/loxp system was used (Kuhn and Torres 
2002).  Cre recombinase (Cre) is an enzyme present in the bacteriophage P1.  This Cre 
binds to loxP sites on the DNA and modifies them.  When there are two loxP sites 
flanking a segment of DNA, cre will excise that segment of DNA into a circular structure 
effectively knocking out the gene.  In this study macrophage specific Lys-cre was used to 
knock out E2F3 in the macrophages of PyMT mice (Clausen et al.,1999). 
Three experimental mice groups were used in this study: PyMT/ E2F3+/loxP 
(control), PyMT/Lys+/-/E2F3+/loxP (conditional), and PyMT/Lys+/-E2F3loxP (homozygous).  
In order to generate the three groups of mice the following breeding scheme was used. 
  
 
   PyMT+/-Lys+/-E2F3+/loxP   X   E2F3loxP 
↓ 
PyMT+Lys+E2F3+/loxP 
PyMT+Lys-E2F3+/loxP
PyMT+Lys+E2F3loxP
 
  
Genotyping and Sorting: 
 
Mice were tailed in the 17-21 day range.  DNA was isolated from these tails by 
the addition of tail buffer and proteinase K overnight in the incubator.  The tail buffer 
allowed ProK to digest any protein present within the tail allowing for easy extraction of 
the DNA.  After the digestion, the samples were centrifuged at 14,000rpm for 10 minutes.  
The supernatant was transferred to a fresh tube containing 500ul of isopropanol.  The 
samples were shaken vigorously to allow the DNA to precipitate.  The remnants of the 
tail buffer were removed by washing with 80% ethanol and then letting the DNA dry.  
The final step was the addition of low TE EDTA to the samples which allowed the DNA 
to dissolve in solution.  After 30 minutes of incubation, the DNA was ready for PCR 
analysis. 
 Three PCR reactions were done (E2F3, PyMT, and Lys cre) to determine the 
genotype of the mice.  A PCR (Polymerase Chain Reaction) is an enzymatic reaction that 
allows for the amplification of a specific segment of DNA.  The reagents used in these 
PCR reactions were: 10x Buffer, MgCl2, dNTPs, water, a set of PCR specific primers (2 
or 3 depending on the PCR protocol), and a polymerase (usually Therophillus aquaticus).  
6x loading dye was added to the reaction and it was run on a 2% agarose gel prepared 
with Ethidium Bromide.  Afterwards it is analyzed on the Alpha imaging machine using 
UV light. 
  
FACS 
 To test for E2F3 deletion in macrophages tumor and lung tissue samples were 
sorted using a flow cytometry technique.  First, tumors were removed from the mice and 
digested with collagenase to make a cell suspension.  Then they were sorted using PE 
conjugated F4/80 antibodies.  After sorting, DNA was made from the macrophages and 
an E2F3 PCR was done to test for deletion.  The lung was lavaged with cold PBS 
solution to isolate macrophages.  
 
Tumor analysis: 
 
Starting at 50 days of age the mice were monitored twice a week for tumor 
progression.  They were palpitated to feel for tumors.  When the tumors were ~ 5mm in 
size it, the size and position of the tumor was recorded as the primary tumor and it 
became the focus of the measurement.  The tumor was measured using an electronic 
caliper, and once the primary tumor was labeled, it was the only tumor measured.  Mice 
were sacrificed when they were 110 days of age; they were sacrificed earlier if they fit 
ERC (Early Removal Criteria).  The ERC was based on how difficult it was for the 
mouse to move, and if the tumors had reached a point in which the mouse had become 
lethargic.   
 
Necropsy: 
 
After 110 days (or earlier depending on ERC), each mouse in the study was humanely 
sacrificed and dissected.  The mammary tumor was carefully removed using scissors and 
forceps.  Each tumor was individually weighed and measured using a caliper.  The 
tumors were then stored in 50 ml conical tubes filled with formalin. The primary tumor 
was stored in a separate conical tube along with the liver.  Finally, the lungs were inflated 
by inserting a syringe into the trachea of the mouse with formalin.  The lung was then 
removed and placed in the same conical tube that contained the primary tumor. The 
mouse carcass was then properly disposed. 
 
Lung analysis and Histology 
 
Each lung was separated into its 5 individual lobes, and sent into histology for 
staining.  The staining protocol is as follows; Dehydration (70% ethanol for 30 minutes, 
95% ethanol 30 minutes, 100% ethanol 30 minutes, xylene 30 minutes), Rinse with water 
10 minutes, Hydrate (100% ethanol for 30 minutes, 95% ethanol 30 minutes, 70% 
ethanol 30 minutes), Rinse with water 10 minutes, Dry the cassettes, Mayer Hemotoxylin 
for 1 minute, Rinse with water for 20 minutes, 1%HCL for 20 minutes, Rinse with water 
20 minutes, Dehydrate, then store in glass container with methyl salicylate.   
 
Lung statistical analysis 
 
 Lung pictures are taken using a dissecting microscope, and they are analyzed for 
metastasis using the ImageJ program.  This program allows for the measurement of the 
area of the total tumor mass present in the lung.  First, each individual tumor on the lung 
picture is circled.  The total number is recorded.  After all the tumors have been circled, 
ImageJ allows for the area of all the tumors to be calculated.  After this calculation, the 
entire lobe of the lung is circled and its area is measured.  Dividing the tumor area by the 
lung area gives the area of metastasis. 
 
Results 
Lys cre efficiency: 
 The purpose of the E2F3 PCR was not only for genotyping purposes, but also to 
check the efficiency of Lys cre.  Lung and tumor macrophages were isolated using the 
flow cytometry technique.  Lungs were lavaged with cold PBS and tumors were digested 
with collagenase.  The macrophages were sorted using PE conjugated F480 antibody.  An 
E2F3 PCR was done to determine E2F3 deletion as seen in (Figure 1). Macrophages 
isolated from tumors and lungs of mice showed 50% deletion in E2f3 +/loxp and E2f3 
loxp/loxp groups. 
E2f3-/- 
E2f3 loxp/loxp
E2f3+/+ 
500 bp 
396 bp 
220 bp 
 
Figure 1. Macrophage samples isolated from tumors and lungs.  E2f3 loxp/loxp (Lane 1,3, 4, 
and 6) and E2f3 +/loxp (Lane 2 and 5). 
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 Rosa lox staining was done to study the expression in the mammary gland of Lys 
cre.  Mice were created with the Rosa-LacZ gene expression in the macrophages by 
crossing Rosa-lox mice with Lys-cre mice.  Lungs and mammary glands from these mice 
were isolated then stained with X-gal. The results show that only macrophages were 
staining positive for Lac-Z as indicated by Figure 2.  Also, macrophages appear to be 
congregating around the exterior boundary of the tumors.  Therefore, Lys cre was indeed 
targeting the macrophages. 
 
 
+ Cre 
- Cre 
+ Cre 
- Cre 
DC 
A B
 
Figure 2. Rosa-lox mice with LacZ staining of lungs and tumors.  A shows a Lys-cre+ 
lung with tumors.  The circular dots are presumed to be macrophages gathered around a 
tumor.  B Lys-cre+ but normal lung has no tumors.  Macrophages are still present.  C and 
D show lungs with and without tumors however without Lys-cre.   
 
 
 
Tumor data collection: 
  
 The groups of mice were generated for this study: PyMT/E2F3+/loxP (control), 
PyMT/Lys+/-/E2F3+/loxP (conditional), and PyMT/Lys+/-E2F3loxP (homozygous).  The 
control group contained 37 mice, the conditional group had 20, and the homozygous had 
15.  As described in Materials and Methods, mice were palpitated for tumors twice a 
week in the mouse facility.  Mice have 10 mammary glands (5 on each ventral lateral, 
Figure 3). 
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Figure 3. Ventral side of mouse showing the location of the mammary glands 
 
  Once tumors met reached a size of ~5 mm they were then measured weekly with 
an electronic caliper.  After mice reached 110 days of age or if they meet the ERC 
criterion they were harvested for their tumors and lungs.  Tumors were collected, 
weighed, and a final measurement was taken with a caliper.  The tumor data for all three 
groups is presented in Figure/Table X.  The control (E2F3+/loxP – cre) group had an 
average age of onset of 78.71 (+/– 10.91) days.  The conditional (E2F3+/loxP+cre) and 
(E2F3loxP/loxP) homozygous groups had 79.24 (+/- 11.37) and 81.81 (+/- 8.08) days 
respectively.   Figure X better demonstrates the similarities in age of onset and data 
points.  As it shows, each group of mice are similar in terms of age of onset.  Tumor 
burden (%) was calculated by weighing all the tumors and dividing it by the weight of the 
mouse during necropsy.  It represents the % body weight that the tumors encompass.  In 
the control (E2F3+/loxP – cre) group, tumor burden was 43.78 (+/- 8.03) percent.  The 
conditional (E2F3lox+/p) group and homozygous (E2F3loxp/loxp) had 43.34 (+/- 8.44) and 
46.31 (+/- 8.44) %, respectively (Figure 4).  Data tables for all the groups are shown in 
figure 5a-5c. 
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Figure 4. Two graphs showing % tumor burden and age of onset in the three 
experimental groups of mice.  Wt represents the control group, ch is the conditional 
group, and ff is the homozygous group.   
 
 
 
 
 
  
 
ID 
Age of 
Onset 
Age of 
Death Animal Tumor 
Tumor 
Burden Metastasis 
   Days   
mass 
(g) 
mass 
(g) (%)   
             
Pye3Fa3 61 110 37.8 19 50.26 14.98 
Pye3Fb3 83 105 44 21.7 49.32 27.89 
Pye3Fb4 83 105 43.2 23.1 53.47 22.06 
Pye3Fc1 75 107 38.4 20 52.08 56.15 
Pye3Ff13 97 112 38.7 11.9 30.75 4.07 
Pye3Fe4 88 110 41.2 16.7 40.53 3.96 
Pye3Fl3 74 101 38.6 12.7 32.90 11.52 
Pye3Fm5 84 110 34.7 9.8 28.24 2.03 
Pye3Fs1 78 110 44.6 19.1 42.83 17.73 
Pye3Fu7 73 105 41.7 21.2 50.84 0.32 
Pye3Fv5 91 110 33.8 14.8 43.79 5.3 
Pye3Fu9 86 110 24.5 9.7 39.59 67 
Pye3Fy6 61 110 33 17.8 53.94 7.32 
Pye3F(II)b3 60 99 50 25.3 50.60 1.63 
Pye3(II)c7 76 110 44.5 23.15 52.02 27.47 
Pye3(II)c8 80 110 44 21.06 47.86 23.3 
Pye3F(II)e6 68 110 46.9 22.4 47.76 5.70 
Pye3F(II)e7 90 110 36 11.8 32.78 1.10 
Pye3F(II)e9 90 110 31.5 11.8 37.46 8.40 
Pye3F(II)g3 66 108 26.7 11.9 44.57 51.60 
Pye3F(II)n13 89 110 37.8 14.3 37.83 4.9 
       
AVG 78.71    43.78 17.35 
SD 10.91    8.03  
 
Figure 5a.  Shows all the data for the control group (E2F3+/loxp – cre). 
 
 
 
 
 
 
 
 
  
 
ID 
Age of 
Onset 
Age of 
Death Animal Tumor 
Tumor 
Burden Metastasis 
   Days   
mass 
(g) 
mass 
(g) (%)   
             
Pye3Fl2 78 110 46.3 21 45.36 1.9 
Pye3Fm7 70 110 41.6 17.9 43.03 5.29 
Pye3Fn4 60 110 49.7 22.7 45.67 2.49 
Pye3Fp2 56 110 47.6 21.1 44.33 17.64 
Pye3Fs3 84 110 40.6 16.9 41.63 8.28 
Pye3Fu11 104 110 40.5 18.7 46.17 11.4 
Pye3Fx1 67 109 46.5 27.1 58.28 7.2 
Pye3F(II)e12 68 110 33.5 9.9 29.55 1.5 
Pye3F(II)g5 82 111 36.5 15.9 43.56 4.20 
Pye3F(II)i2 97 110 32.2 9.5 29.50 0.6 
Pye3F(II)j6 84 110 39.6 15.5 39.14 2.57 
Pye3F(II)m2 85 110 42.7 17.7 41.45 1.02 
Pye3F(II)m3 84 110 40.1 20.8 51.87 13.90 
Pye3F(II)n15 89 110 43.3 22.1 51.04 4.30 
Pye3F(II)p6 73 110 37.1 14.8 39.89 0.80 
Pye3F(II)p10 87 110 34.4 11.7 34.01 2.78 
Pye3F(II)q5 83 110 40.5 17.6 43.46 4.00 
Pye3F(II)q7 73 110 44.5 25.3 56.85 2.10 
Pye3F(II)s7 84 110 37.85 14.6 38.57 2.9 
Pye3F(III)b6 78 110 43.9 25.5 58.09 8.7 
Pye3F(III)b8 78 110 41.12 23 55.93 1.84 
       
AVG 79.92    43.34 5.02 
SD 11.37    8.44  
 
Figure 5b.  Shows all the data for the conditional group (E2F3+/loxp + cre). 
 
 
 
 
 
 
 
 
  
 
ID 
Age of 
Onset 
Age of 
Death Animal  Tumor 
Tumor 
Burden Metastasis
   Days   mass (g) mass (g) (%)   
             
Pye3F(II)q8 83 110 36 17.1 47.50 0.3
Pye3F(II)s3 91 110 38.9 17.55 45.12 27.97
Pye3F(II)t4 89 110 39.7 15.41 38.82 2.79
Pye3F(II)y4 70 110 46.4 28.8 62.07 11.73
Pye3F(III)e6 79 111 39.6 17.6 44.44 23.51
Pye3F(III)f8 78 110 37.6 18.1 48.14 0.82
Pye3F(III)f11 85 110 37.7 17.1 45.36 4.64
Pye3F(III)i1 75 107 40 16 40 3.31
Pye3F(III)i5 72 107 41.6 18.3 43.99 1.43
Pye3F(III)k14 84 110 42 21.9 52.14 5.22
Pye3F(III)m4 78 111 37.8 15.7 41.53 0.31
Pye3F(III)r3 79 109 50.78 27.4 53.96 10.9
Pye3F(III)s3 72 109 44.3 22.7 51.24 2.9
Pye3F(III)s6 82 110 48 12.4 25.83 4.15
Pye3F(III)t6 97 111 34.7 11.7 33.72 0.16
Pye3F(III)u3 95 110 36.8 14.9 40.49 1.26
       
AVG 81.81   46.31 6.34 
SD 8.08   8.44 
 
Figure 5c.  Shows all the data for the homozygous group (E2F3loxp/loxp + cre).  
 
 
 
 
 
 
 
 
 
 
 
  
Lung Data collection: 
 
 The Lungs were kept in formalin and sent to the histology lab for staining with 
Mayer Hemotoxylin.  The staining allowed the tumors to be easily distinguished from 
normal lung tissue (Figure 6). 
 
 
PyMT E2F3+/loxP + Cre 
PyMT E2F3+/loxP - Cre 
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B
 
  PyMT E2F3
loxp/loxP + Cre
 
Figure 6. The 3 groups of experimental mice with Mayer hemotoxylin staining (further 
described in materials and methods. 
 
 
The protocol for the lung staining is described in the materials and methods section of the 
paper.  Once stained, pictures were taken of each of the 5 lobes of the lung using a 
dissecting microscope and the appropriate microscope software.  These pictures were 
then analyzed using software provided by the NIH called ImageJ.  With ImageJ, the lung 
picture (1 picture for each lobe, a total of 5 per lung) was opened and then analyzed.  
ImageJ allows for the measurement of area within a picture.  First the total area of the 
tumors within the lobe was measured.  Each tumor was completely encircled in order to 
account for its area.  This was repeated for every tumor within the lobe until all were 
accounted.  Once this was done, the area was summed up and measured.  The number of 
tumors within each lobe was also recorded.  After the total tumor area was calculated by 
ImageJ, the total lobe area was calculated by encircling the entire lung lobe.  Thus the 
total tumor area was divided by the total lobe area and result was the % metastasis of the 
lobe.  This process was repeated for all five lobes and the % metastasis and number of 
tumors was averaged.  
 The results of the Metastasis and number of tumors are summarized in Figure 7. 
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Figure 7. The graph shows metastatic area for all three groups of mice.  For         
E2F3+/loxp - cre The average metastatic area was 17.35;  For E2F3+/loxp + cre it was 5.02; 
for E2F3loxp/loxp + cre it was 6.34              
 
The average percent metastatic area for wild type is 17.35% while it is 5.02% for the 
conditional group is.  The homozygous group shows results similar to the conditional 
group and its percent metastatic area is 6.34%.  Lung metastasis was measured both 
qualitatively and quantitatively.  The t-test between the conditional and control group 
shows the p-value to be 0.004 meaning that it is statistically significant.  The t-test 
between the control and homozygous group shows a p-value of 0.013 which is also 
statistically significant.   
 
 
 
 
 
 
Discussion 
 
Tumor analysis 
 
The results showed that age of onset and tumor burden was similar among the three 
groups of mice. Therefore, macrophages don’t play a critical role in tumor growth.  This 
data was expected since tumors are composed almost entirely of epithelial cells.  Also, 
macrophages are post-mitotic cells, so their cell-cycle would not be affected.  Deleting 
E2F3 in macrophages did not have an effect on the epithelial cells and their proliferation.  
 
Lung analysis 
The interesting results arose from the analysis of the lung.  In terms of metastasis, the 
control group showed more then a three-fold difference when compared to the +/loxP 
group.  These results support the hypothesis that macrophages play a role in metastasis.  
Macrophages with 50% deletion of E2F3 led to a dramatic change in the size and number 
of metastasis in the lung.  However, the homozygous group which theoretically should’ve 
had 100% deletion of E2F3 instead had similar results to the conditional group.  The 
reason appears to be that Lys-cre dramatically loses efficiency when trying to delete two 
alleles as opposed to only needing to delete one allele.  In other words, there is a limit to 
the Lys-cre efficiency. 
 
Role of E2Fs in cell cycle and metastasis 
 
E2Fs are important regulatory genes within the cell cycle.  Based on tumor F4/80 
staining, E2F3 doesn’t seem to affect macrophage proliferation to any discernable degree.  
However, the results of the lung analysis study show that E2F3 does affect macrophages 
based on the decrease in metastasis.  The question is how does E2F3 interfere with 
normal macrophage function?  Previous studies on other cell types have shown that 
deletion of an E2F leads to a decrease in proliferation and a lower number of cells.  The 
E2F3 gene is acting in another way within the macrophage and it certainly seems that the 
CSF-1 pathway might be involved.  The current hypothetical mechanism for TAM 
metastasis seems to be the ability of macrophages to release proteases.  These proteases 
are thought to degrade the outer epithelial lining of the tumor and allow malignant 
epithelial cells to escape within the bloodstream.  
Further hypothetical thinking suggests a link between E2F3 and CSF-1 an important 
macrophage pathway that controls the expression of early and late response genes.  Since 
macrophage proliferation is being affected by E2F3 deletion, maybe gene expression of 
these proteases is being affected along with the CSF-1 pathway. 
 
Clinical application 
 
In the clinical sense avoiding metastasis is the physician’s number one concern while 
treating a cancer patient.  Metastasis is what makes cancer so deadly.  Based on the 
results of the experiment and other publications, macrophages play a key role in 
metastasis.  Thus, being able to control the macrophage population within a tumor might 
decrease the chances of the tumor spreading and therefore increase a patient’s outlook on 
life.  A drug that could somehow reduce macrophage activity within the tumor or repress 
the gene expressing the proteases in TAMs is a more viable alternative. 
 
Areas of further research 
 
Future experiments should seek to understand what genes are being affected within the 
macrophage by the deletion of E2F3.  A micro-array or other gene expression tool could 
be used to answer this question.  Most importantly, are proteases being down-regulated 
and are these proteases responsible for allowing metastasis occur.  
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